Screening for New Agonists Against Alzheimer's Disease

E-ISSN： 1875-6638|3|5|488-493

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.3, Iss.5, 2007-09, pp. : 488-493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Muscarinic agonists for the treatment of Alzheimer's disease: progress and perspectives

By Fisher A.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1395-1412

Informa Healthcare

Access to resources Recommend Favorite

Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M 1 receptors

By Messer W.S. Rajeswaran W.G. Cao Y. Zhang H.-J. El-Assadi A.A. Dockery C. Liske J. O'Brien J. Williams F.E. Huang X.-P. Wroblewski M.E. Nagy P.I. Peseckis S.M.

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 135-140

Elsevier

Access to resources Recommend Favorite

Fighting Against Alzheimer#39;s Disease: Synthesis of New Pyrazoline and Benzothiazole Derivatives as New Acetylcholinesterase and MAO Inhibitors

Letters in Drug Design & Discovery, Vol. 15, Iss. 4, 2018-03 ,pp. : 414-427

Bentham Science Publishers

Access to resources Recommend Favorite

Muscarinic M₁ agonists in the treatment of Alzheimer’s disease

By Korczyn A.D.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2259-2267

Informa Healthcare

Access to resources Recommend Favorite

A Vaccine Against Alzheimer's Disease: Developments to Date

By Vickers J.C.

Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. : 487-494

Adis International

Access to resources Recommend Favorite